COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Marley Spoon Group SE (von NuWays AG): Kaufen
Marley Spoon Group SE released healthy Q1'24 results in line with expectations, with a focus on subscriber growth, improved margins, and confirmed FY'24 guidance. NuWays AG provided an update and recommended buying with a target price of EUR 7.00 -
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE
Defence Therapeutics Inc. successfully completes pre-clinical trial using its ARM-002 anti-cancer vaccine against pancreatic cancer, showing therapeutic effectiveness and potential benefits -
COMMUNIQUÉ DE PRESSE
CBo Territoria governance evolution
The Board of Directors of CBo Territoria announces governance changes, including the resignation of Mr. Eric Wuillai as Chairman. Géraldine Neyret Gleizes to take on the role of Chairman and CEO. Financial calendar includes the Annual Shareholders' Meeting on May 2, 2024
